Antidepressants Flashcards
SSRis
Fluoxetine, olanzapine-fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram
Nonselective norepinephrine-serotonin reuptake inhibitors
Tricyclic:
amitriptyline, nortriptyline, imipramine, doxepin, trimipramine maleate, amoxapine, desipramine, protriptyline hydrochloride, clomipramine
Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Venlafaxine (Effexor), duloxetine, (Cymbalta), milnacipran (Savella), desvenlafaxine (Pristig)
Tricyclic antidepressants:
amitriptyline pharmacodynamics
Act on neurotransmitters, serotonin, and norepinephrine (NE), block reuptake in presynaptic neuron.
and histamine and acetylcholine
Tricyclic antidepressants:
amitriptyline ADRs
paradoxical diaphoresis, causing anticholinergic effects (dry mouth), orthostatic hypotension, sedation, drowsiness
Tricyclic antidepressants:
amitriptyline patient education
Do not discontinue abruptly; avoid OTC medications that stimulate, insomnia or drowsiness.
Must let provider know if having myocardial infarction, glaucoma . avoid in glaucoma
Tricyclic antidepressants:
amitriptyline caution and contraindications
cardiovascular disease
Tricyclic antidepressants:
amitriptyline monitoring
Must report any chest pain
Reassess patient after 2 to 4 weeks of starting medications: suicide, ADRs
Baseline electrocardiography (EKG).
SSRI pharmacodynamics
All SSRIs have selective inhibitory effects on presynaptic serotonin reuptake and weak effects on NE and dopamine neuronal uptake.
Other wording:
affect the serotonin neurotransporter system in the synaptic cleft by blocking the serotonin transporter from returning remaining serotonin to the presynaptic cell. So through this mechanism, more serotonin is available to bind with the postsynaptic receptors.
SSRI ADRs & BBW
CNS, n/v/d, sexual dysfunction
Serotonin syndrome , upper GI bleed, hyponatremia, QTC prolongation, headache
BBW: increased risk of suicidal thinking/behavior in childre, adolescent and young adults.
Major depressive disorder and other psych disorders/
SSRI patient education
May take 2-6 weeks to see maximum effects
Pregnancy: evaluate risk v. benefit
Pediatrics: fluoxetine first line
Withdrawal symptoms if abruptly discontinued
SSRI patient monitoring
Never give more than 4 weeks on first prescription.
Monitor target symptoms.
SNRI indications:
duloxetine, venlafaxine
Major depressive disorder, general anxiety disorder, neuropathy pain, fibromyalgia
SNRI pharmacodynamics
Inhibit reuptake of both norepinephrine and serotonin.
boost dopamine in prefontal cortex
SNRI ADRs
Headache, somnolence, dizziness, insomnia, fatigue, dry mouth, constipation, orthostatic hypotension, erectile dysfunction, ejaculation failure
SNRI patient education
Adherence, suicide ideation, avoidance of OTC medications that stimulate, insomnia or drowsiness, suicide ideation
SNRI monitoring
May increase serum transaminase levels: Watch in patients with liver disease.
Monitor suicide risk, activation of hypomanic or manic symptoms
atypical antidepressants:
buproprion (wellbutrin, zyban) and Mirtazapine (remeron)
pharmacodynamics
Exact mechanism of action unknown
Mirtazapine is a antagonist of 5-HT2, 5-HT3 and histamine (H1) receptors
buproprion (wellbutrin, zyban) and Mirtazapine (remeron) contraindications
seizure disorder
buproprion (wellbutrin, zyban) and Mirtazapine (remeron) ADRs
Bupropion may cause insomnia.
Mirtazapine causes drowsiness, greater at 15 mg/ day than at 30 mg/day.
buproprion (wellbutrin, zyban) and Mirtazapine (remeron) monitoring
depression and suicide
buproprion (wellbutrin, zyban) and Mirtazapine (remeron) patient education
Take mirtazapine before bedtime because it may cause drowsiness
Wellbutrin does not have the sexual dysfunction side effect like SSRIs.
typical antipsychotics
Phenothiazine: chlorpromazine (Thorazine), prochlorperazine.
Non Phenothiazines: haloperidol (Haldol)